Effect of Levocarnitine on Contrast-induced Nephropathy in Coronary Artery Disease Patients After Percutaneous Coronary Intervention / 中国循环杂志
Chinese Circulation Journal
;
(12): 116-118, 2016.
Article
in Chinese
| WPRIM
| ID: wpr-487074
ABSTRACT
Objective:
To investigate the effect of levocarnitine on contrast-induced nephropathy (CIN) in coronary artery disease (CAD) patients after percutaneous coronary intervention (PCI).Methods:
A total of 138 CAD patients with PCI were studied. Upon basic hydration, the patients were divided into 2 groupsLevocarnitine group, the patients received intravenous infusion of levocarnitine 2g at 24h before PCI and levocarnitine 2g/day after PCI for 4 days and Non-levocarnitine group. n=69 in each group. Blood levels of urea nitrogen (BUN), creatinine (Scr), creatinine clearance rate (Ccr) and the occurrence rate of CIN were compared between 2 groups at 24h and 72h after PCI. All contrast agent used in the operation was Ultravist non ionic low permeability contrast solution and the dosage was recorded during operation.Results:
Compared with Non-levocarnitine group, Levocarnitine group had decreased blood levels of BUN and Scr at 24h and 72h after operation;increased post-operative Ccr, all PConclusion:
Application of levocarnitine has certain preventive and protective effect for CIN occurrence in CAD patients after PCI.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Chinese Circulation Journal
Year:
2016
Type:
Article
Similar
MEDLINE
...
LILACS
LIS